Comparing the effectiveness of pharmacist-managed warfarin anticoagulation with other models: a systematic review and meta-analysis

Journal of Clinical Pharmacy and Therapeutics

Volumn 41, Issue 6, 2016, Pages 602-611

  Zhou, S ^a   Sheng, X Y ^a   Xiang, Q ^a   Wang, Z N ^a   Zhou, Y ^a   Cui, Y M ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

anticoagulation; managed care; meta analysis; pharmacists; warfarin

Indexed keywords

WARFARIN; ANTICOAGULANT AGENT;

ADVERSE OUTCOME; ANTICOAGULANT THERAPY; BLEEDING; COMPARATIVE EFFECTIVENESS; DRUG SAFETY; HUMAN; META ANALYSIS; MORTALITY; PATIENT CARE; PATIENT SATISFACTION; PHARMACIST; PHARMACIST MANAGED CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; THROMBOSIS; TREATMENT OUTCOME; BLOOD CLOTTING; CHEMICALLY INDUCED; DRUG EFFECTS; HEMORRHAGE; HOSPITAL EMERGENCY SERVICE; HOSPITALIZATION; NURSE; PHYSICIAN; PROCEDURES; SELF CARE;

ANTICOAGULANTS; BLOOD COAGULATION; EMERGENCY SERVICE, HOSPITAL; HEMORRHAGE; HOSPITALIZATION; HUMANS; NURSES; PATIENT SATISFACTION; PHARMACISTS; PHYSICIANS; SELF CARE; WARFARIN;

EID: 84990842207     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/jcpt.12438     Document Type: Review

References (37)

1. Hirsh J, Fuster V, Ansell J et al. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. J Am Coll Cardiol, 2003;41:1633–1652.
2. You JJ, Singer DE, Howard PA et al. Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest, 2012;141:e531S–e575S.
3. Guyatt GH, Akl EA, Crowther M et al. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest, 2012;141:7S–47S.
4. Wysowski DK, Nourjah P, Swartz L. Bleeding complications with warfarin use: a prevalent effect resulting in regulatory action. Arch Intern Med, 2007;167:1414–1419.
5. Saokaew S, Permsuwan U, Chaiyakunapruk N et al. Effectiveness of pharmacist-participated warfarin therapy management: a systematic review and meta-analysis. J Thromb Haemost, 2010;8:2418–2427.
6. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med, 1998;158:1641–1647.
7. Chamberlain MA, Sageser NA, Ruiz D. Comparison of anticoagulation clinic patient outcomes with outcomes from traditional care in a family medicine clinic. J Am Board Fam Pract, 2001;14:16–21.
8. Ansell J, Hirsh J, Dalen J et al. Managing oral anticoagulant therapy. Chest, 2001;119:22S–38S.
9. Wilson SJ, Wells PS, Kovacs MJ et al. Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. CMAJ, 2003;169:293–298.
10. Witt DM, Sadler MA, Shanahan RL et al. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. Chest, 2005;127:1515–1522.
11. Chan FW, Wong RS, Lau WH et al. Management of Chinese patients on warfarin therapy in two models of anticoagulation service - a prospective randomized trial. Br J Clin Pharmacol, 2006;62:601–609.
12. Verret L, Couturier J, Rozon A et al. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy, 2012;32:871–879.
13. Lalonde L, Martineau J, Blais N et al. Is long-term pharmacist-managed anticoagulation service efficient? A pragmatic randomized controlled trial. Am Heart J, 2008;156:148–154.
14. Scott K. Determinants and measures of quality in oral anticoagulation therapy. J Thromb Thrombolysis, 2008;25:61–66.
15. Higgins JGS. Cochrane handbook for systematic reviews of interventions version 5.1. 0 [updated March 2011]. The Cochrane Collaboration [EB/OL]. Available at: http://www.cochrane-handbook.org.
16. Meerpohl JJ, Langer G, Perleth M et al. GRADE guidelines: 3. Rating the quality of evidence (confidence in the estimates of effect). Z Evid Fortbild Qual Gesundhwes, 2012;106:449–456.
17. Canfield SE, Dahm P. Rating the quality of evidence and the strength of recommendations using GRADE. World J Urol, 2011;29:311–317.
18. Perleth M, Matthias K, Langer G et al. GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence. Z Evid Fortbild Qual Gesundhwes, 2013;107:256–268.
19. Gallagher J, Mc CS, Woods N et al. Economic evaluation of a randomized controlled trial of pharmacist-supervised patient self-testing of warfarin therapy. J Clin Pharm Ther, 2015;40:14–19.
20. Bungard TJ, Ritchie B, Garg S et al. Sustained impact of anticoagulant control achieved in an anticoagulation management service after transfer of management to the primary care physician. Pharmacotherapy, 2012;32:112–119.
21. Lakshmi R, James E, Kirthivasan R. Study on impact of clinical pharmacist's interventions in the optimal use of oral anticoagulants in stroke patients. Indian J Pharm Sci, 2013;75:53–59.
22. Jackson SL, Peterson GM, Vial JH et al. Improving the outcomes of anticoagulation: an evaluation of home follow-up of warfarin initiation. J Intern Med, 2004;256:137–144.
23. Schillig J, Kaatz S, Hudson M et al. Clinical and safety impact of an inpatient pharmacist-directed anticoagulation service. J Hosp Med, 2011;6:322–328.
24. Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials, 1996;17:1–12.
25. Bishop MA, Streiff MB, Ensor CR et al. Pharmacist-managed international normalized ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center. ASAIO J, 2014;60:193–198.
26. Copas J, Shi JQ. Meta-analysis, funnel plots and sensitivity analysis. Biostatistics, 2000;1:247–262.
27. Tajer C, Ceresetto J, Bottaro FJ et al. Assessment of the Quality of Chronic Anticoagulation Control With Time in Therapeutic Range in Atrial Fibrillation Patients Treated With Vitamin K Antagonists by Hemostasis Specialists The TERRA Registry: Tiempo en rango en la República Argentina. Clin Appl Thromb Hemost, 2016;14:271–282.
28. Gallego P, Roldan V, Marín F et al. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation. Thromb Haemost, 2013;110:1189–1198.
29. Gallagher AM, Setakis E, Plumb JM et al. Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients. Thromb Haemost, 2011;106:968–977.
30. Camm AJ, Lip GY, De Caterina R et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J, 2012;33:2719–2747.
31. Uk NCGC. Atrial fibrillation: the management of atrial fibrillation[M]. London: National Institute for Health and Care Excellence (UK), 2014.
32. Rosendaal FR, Cannegieter SC, Meer FJVD et al. A method to determine optimal intensity of oral anticoagulant therapy. Thromb Haemost, 1993;69:236–239.
33. Dawson NL, Porter IN, Klipa D et al. Inpatient warfarin management: pharmacist management using a detailed dosing protocol. J Thromb Thrombolysis, 2012;33:178–184.
34. Gouin-Thibault I, Levy C, Pautas E et al. Improving anticoagulation control in hospitalized elderly patients on warfarin. J Am Geriatr Soc, 2010;58:242–247.
35. Stafford L, Peterson GM, Bereznicki LR et al. A role for pharmacists in community-based post-discharge warfarin management: protocol for the ‘the role of community pharmacy in post hospital management of patients initiated on warfarin’ study. BMC Health Serv Res, 2011;11:16.
36. Berg TM, O'Meara JG, Ou NN et al. Risk factors for excessive anticoagulation among hospitalized adults receiving warfarin therapy using a pharmacist-managed dosing protocol. Pharmacotherapy, 2013;33:1165–1174.
37. Chilipko AA, Norwood DK. Evaluating warfarin management by pharmacists in a community teaching hospital. Consult Pharm, 2014;29:95–103.